C. Wurthmann et al., INTERACTION OF THERAPEUTIC EFFECTS AND SI DE-EFFECTS IN PHARMACOTHERAPY OF GENERALIZED ANXIETY DISORDERS WITH LOW-DOSAGE FLUSPIRILENE, Fortschritte der Neurologie, Psychiatrie, 63(2), 1995, pp. 72-77
The present study was designed to investigate the interaction between
therapeutic effects and side-effects in fluspirilene treatment of gene
ralised anxiety disorders (GAD). 205 outpatients received in an open t
rial 1.5mg fluspirilene per week for 6 weeks. Confirming previous repo
rts of our study group fluspirilene demonstrated marked efficacy and w
as generally well tolerated. However, the main finding of our study is
that side effects, although rare in fluspirilene treatment, predict a
n unfavourable clinical outcome. This phenomenon is integrated in a ps
ychological model implying that when GAD patients are aware of side-ef
fects this induces anxiety. Again anxiety gives rise to somatic sympto
ms, both interacting in a forward loop. In conclusion, our data sugges
t that in the sense of Heinrich (1988) fluspirilene treatment of GAD s
hould be guided by paying attention to possible side effects.